Related Experiment Videos
Neuropharmacology in the elderly
1Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Rush College of Medicine, Chicago, Illinois 60612, USA.
Neurologic Clinics
|July 17, 1998
Summary
Psychotropic medications require special consideration in older adults due to age-related changes in how the body processes drugs (pharmacokinetics) and responds to them (pharmacodynamics). Physicians must address polypharmacy and other issues for safe prescribing.
Area of Science:
- Geriatric Pharmacology
- Psychiatric Drug Management
Background:
- Psychotropic medications pose unique challenges in elderly populations.
- Aging significantly alters drug absorption, distribution, and elimination (pharmacokinetics).
- End-organ responsiveness to medications changes with age (pharmacodynamics).
Purpose of the Study:
- To highlight the complexities of psychotropic drug use in the elderly.
- To inform physicians about age-related physiological changes impacting medication efficacy and safety.
Main Methods:
- Review of pharmacokinetic and pharmacodynamic alterations in aging.
- Identification of common complicating factors in psychotropic prescribing for seniors.
Main Results:
- Age-related changes in pharmacokinetics and pharmacodynamics necessitate careful dosing and selection.
- Polypharmacy, poor compliance, diagnostic uncertainty, and coexisting illnesses complicate treatment.
- Physician awareness of these factors is crucial for effective and safe psychotropic prescribing.
Conclusions:
- Prescribing psychotropic medications for the elderly requires a thorough understanding of geriatric-specific physiological changes.
- Addressing challenges like polypharmacy and comorbidities is essential for optimizing therapeutic outcomes and minimizing risks in older patients.